∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 /CNW/ -- Accord Healthcare today announced the launch of ...
The Oscar race for visual effects is down to 20. With multiple sources confirming to Variety, the list of finalists includes a mix of anticipated blockbusters and franchise entries, with major studios ...
The United States announced new, higher tariff rates this year. Tariffs can affect supply chains, investment, and firms’ input costs, resulting in supply-side effects such as higher inflation and ...
More than a third of Americans who were vaccinated against COVID-19 say they had side effects from the shot, and nearly half suspect the vaccines killed many patients, The latest Rasmussen Reports ...
Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, interchangeable with Prolia and Xgeva, respectively. Clinical trials confirmed ...
Products will treat osteoporosis and skeletal-related events from certain types of bone cancer, expanding the company's biosimilar portfolio Approved for all of the same indications of its reference ...
FDA approves multiple denosumab biosimilars, enhancing market access and introducing interchangeability, boosting competition in bone health therapies. The competitive landscape for biosimilar ...
There is basically no research that looks at the impact of antidepressants on emerging sexuality. Here are the key things we do know. By Daniel Bergner S.S.R.I.s, the most commonly prescribed class of ...
THOUSAND OAKS, Calif., July 15, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Lancet Oncology published planned interim results from an international, open-label, Phase 2 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback